Cargando…
Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
Respiratory syncytial virus (RSV) is one of the main pathogens associated with lower respiratory tract infections in infants and young children worldwide. Exosomes secreted by antigen presenting cells (APCs) can elicit immune responses by carrying major histocompatibility complex (MHC) class I molec...
Autores principales: | Hong, Suyeon, Ruan, Shaobo, Greenberg, Zachary, He, Mei, McGill, Jodi L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560785/ https://www.ncbi.nlm.nih.gov/pubmed/34725399 http://dx.doi.org/10.1038/s41598-021-00765-x |
Ejemplares similares
-
Supplementing a Saccharomyces cerevisiae fermentation product modulates innate immune function and ameliorates bovine respiratory syncytial virus infection in neonatal calves
por: Mahmoud, Asmaa H A, et al.
Publicado: (2020) -
Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
por: Tripp, Ralph A., et al.
Publicado: (2019) -
A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
por: Díaz, Fabián E., et al.
Publicado: (2021) -
Neonatal Calf Infection with Respiratory Syncytial Virus: Drawing Parallels to the Disease in Human Infants
por: Sacco, Randy E., et al.
Publicado: (2012) -
Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
por: Altamirano-Lagos, María José, et al.
Publicado: (2019)